Summerlin Hospital Adds New Technology to Improve Detection of Certain Bladder Cancers
Wednesday, June 20, 2018
![Senior man talking to doctor](https://www.valleyhealthsystemlv.com/sites/valleyhealthsystemlv.com/files/styles/feature_image/public/images/news/senior-man-talking-to-dr-671211056.jpg?itok=r4k983yF)
In its ongoing commitment to the detection and treatment of cancer, Summerlin Hospital now offers Blue Light Cystoscopy with Cysview®, an optical imaging agent for the detection of papillary cancer of the bladder in patients with known or suspected bladder cancer. Cysview is the only FDA-approved imaging agent for use with blue-light cystoscopy.